I. Introduction
II. Worldwide Market Overview
1. Business Environment
2. Market Structure
3. Market Size and Growth
4. POC Testing Market
III. Major Product Development Opportunities
IV. Design Criteria For Decentralized Testing Products
V. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
VI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VII. Worldwide Market and Technology Overview
A. Major Routine and Special Coagulation Tests
1. Introduction
2. Activated Partial Thromboplastin Time (APTT)
3. Alpha-2 Antiplasmin
4. Antithrombin III
5. Bleeding Time
6. D-Dimer
7. Ethanol Flocculation Test
8. Euglobulin Lysis
9. Factor Assays
a. Introduction
b. Factor II
c. Factor V/Factor V Leiden
d. Factor VII
e. Factor VIII
f. Factor IX
g. Factor IXa
h. Factor X (Stuart Factor)
i. Factor Xa
j. Factor XI
k. Factor XII
l. Factor XIII
10. Fibrin Degradation Products
11. Fibrinogen
12. Heparin
13. Hirudin
14. Hypercoagulability and Thrombosis
15. Lipoprotein a
16. Plasmin
17. Plasminogen
18. Plasminogen Activator Inhibitor (PAI)
19. Platelet Function Tests
20. Platelet Aggregation
21. Proteins C and S
22. Prothrombin Fragment 1.2
23. Prothrombin Time (PT)
24. Reptilase Time
25. Thrombin Time
26. Tissue-Type Plasminogen Activator (t-PA)
27. Von Willebrand’s Factor
B. Coagulation Instrumentation Review: Centralized
and POC Testing Analyzers
C. Major Coagulation Testing Technologies
and Their Potential Applications
1. Chromogenic Substrates
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
4. Molecular Diagnostics
5. Microcomputers
6. Automation
7. Robotics
8. Artificial Intelligence
9. Dry Chemistry
10. Biosensors
VIII. France Coagulation Testing Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment,
Major Instrument, Reagent Supplier Sales and Market Shares
IX. Germany Coagulation Testing Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment,
Major Instrument, Reagent Supplier Sales and Market Shares
X. Italy Coagulation Testing Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment,
Major Instrument, Reagent Supplier Sales and Market Shares
XI. Japan Coagulation Testing Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment,
Major Instrument, Reagent Supplier Sales and Market Shares
XII. Spain Coagulation Testing Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment,
Major Instrument, Reagent Supplier Sales and Market Shares
XIII. U.K. Coagulation Testing Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment,
Major Instrument, Reagent Supplier Sales and Market Shares
XIV. U.S.A. Coagulation Testing Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment,
Major Instrument, Reagent Supplier Sales and Market Shares
XV. Competitive Assessments
The report provides strategic assessments of over 20 leading coagulation market
players and start-up companies with innovative technologies and products,
including:
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Diagnostica Stago
Grifols
Helena Laboratories
IL/Werfen
Roche
Sekisui Diagnostics
Siemens Healthineers
Sysmex
Thermo Fisher, and others
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer